Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Tobacco Control|September 13, 2021
Role of affective reactivity induced by cigarette packaging including graphic warning labels: the CASA StudyMatthew Stone, David Strong, Claudiu Dimofte, et al.
American Journal of Health Promotion : AJHP|July 11, 2018
Enrollment Strategies, Barriers to Participation, and Reach of a Workplace Intervention Targeting Sedentary BehaviorSarah L Mullane, Sarah A Rydell, Miranda L Larouche, et al.
Health Economics Review|November 4, 2021
Hospitalization budget impact during the COVID-19 pandemic in SpainF J Carrera-Hueso, L Álvarez-Arroyo, J E Poquet-Jornet, et al.
Plos One|December 19, 2014
Structure and biological roles of Sinorhizobium fredii HH103 exopolysaccharideDulce N Rodríguez-Navarro, Miguel A Rodríguez-Carvajal, Sebastián Acosta-Jurado, et al.
Contemporary Clinical Trials|August 15, 2025
COVID Prevention Program: Rationale and methodology of a tailored behavioral intervention to prevent household and community spread of COVID-19 among LatinosNoe C Crespo, Job Godino, Alma Behar, et al.
American Journal of Preventive Medicine|November 25, 2015
Physical Activity Levels in U.S. Latino/Hispanic Adults: Results From the Hispanic Community Health Study/Study of LatinosElva M Arredondo, Daniela Sotres-Alvarez, Mark Stoutenberg, et al.
Journal of Helminthology|April 25, 2009
Trichinellosis survey in the wild boar from the Toledo mountains in south-western Spain (2007-2008): molecular characterization of Trichinella isolates by ISSR-PCRR N García-Sánchez, J J Nogal-Ruiz, R Manzano-Lorenzo, et al.
Biodiversity Data Journal|May 24, 2014
Spatial distribution of Madeira Island Laurisilva endemic spiders (Arachnida: Araneae)Luís C Crespo, Mário Boieiro, Pedro Cardoso, et al.
Neurologia (Barcelona, Spain)|June 11, 1999
The PDQ-39 Spanish version: reliability and correlation with the short-form health survey (SF-36)P Martínez Martín, B Frades, F J Jiménez Jiménez, et al.
BMC Infectious Diseases|February 23, 2023
COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health CenterNatalie L Vawter, Job G Godino, Sydney V Lewis, et al.
Pageof 22